- Industry calls for urgent clarity on EU workers as survey shows recruitment crunch looming
- Cortec® Introduces EcoShield® Super Barrier Paper and Linerboard
- Daimler launches new DENZA electric vehicle for the Chinese market
- Rimac opens 100 new jobs
- Covestro expands global capacity for polyurethane dispersions
- Amey and Sersa, as part of the S&C North Alliance, win Infrastructure Achievement Award at National Rail Awards
- European Commission Approves Symtuza® for the Treatment of HIV-1 In Adults and Adolescents in Europe
- BNP Paribas takes further measures to accelerate its support of the energy transition
Chemicals and Pharmaceuticals
Univar Inc, a global chemical and ingredient distributor and provider of value-added services, announced today that it will expand its relationship with The Dow Chemical Company to include exclusive distribution rights for UCON™ Fluids and Lubricants in North America.
Clariant, a world leader in speciality chemicals, has announced full year 2017 sales of CHF 6.377 billion compared to CHF 5.847 billion in 2016.
Versalis, Eni’s chemicals company and a major player in the polymers and elastomers industry, and Bridgestone Americas (Bridgestone), the leading global producer in the tyre industry, have signed a strategic partnership agreement to develop and deploy a comprehensive technology package to commercialise Guayule in the agricultural, sustainable-rubber and renewable-chemical sectors.
Solvay, a leading global supplier of high-performance polymers, announced today that Advanced Sensor Technologies Inc. (ASTi) selected Ryton® polyphenylene sulphide (PPS) to mould protective housings for two industrial-grade sensors.
The Board of Directors of Kemira Oyj has resolved to continue the long-term share-based incentive plan directed to a group of key employees in Kemira.
Clariant, a world leader in speciality chemicals, has announced the completion of testing on ingredients in its MEVOPUR and REMAFIN-EP product ranges to bring them into full compliance with USP <661.1>.
Sailors from team AkzoNobel joined company employees and residents from a neighborhood in downtown Guangzhou, China, today to unveil a special mural created by the winner of a student design competition.
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced a new clinical collaboration with AstraZeneca to evaluate the safety and efficacy of AstraZeneca's durvalumab, a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1), in combination with SNDX-6352, Syndax's monoclonal antibody inhibitor of Colony-Stimulating Factor 1 Receptor (CSF1R), across a variety of solid tumors.